The Impact of Glycaemic Variability on Vascular Dysfunction in Diabetes
Laura J Offler1, Liz K Wells2, Timothy M Palmer1
1Biomedical Institute for Multimorbidity, Hull York Medical School Centre for Biomedicine, Faculty of Health Sciences, University of Hull, Hull HU6 7RX, UK.
Biomolecules
|November 27, 2025
Summary
Poorly controlled diabetes leads to vascular dysfunction and heart risks. This review explores how high blood sugar impacts blood vessels and potential new treatments for diabetic cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Diabetes Mellitus Research
Background:
- Vascular dysfunction is prevalent in diabetes mellitus, increasing risks of heart attack, stroke, and peripheral vascular disease.
- Persistent hyperglycemia in poorly controlled diabetes is a suspected critical factor in vascular complications.
- Existing research spans in vitro, ex vivo, and preclinical models to understand these effects.
Purpose of the Study:
- To review current understanding of how metabolic and cell signaling pathways affected by poor glycemic control impact vascular function in diabetes.
- To evaluate the potential of these pathways for developing targeted therapies to improve cardiovascular outcomes in diabetic patients.
Main Methods:
- Consolidation of findings from multiple experimental studies.
- Analysis of in vitro, ex vivo, and preclinical models.
- Review of research on metabolic and cell signaling pathways in diabetes-related vascular dysfunction.
Main Results:
- Poor glycemic control triggers specific metabolic and cell signaling pathways that negatively affect vascular function.
- These pathways offer potential targets for therapeutic intervention.
- Understanding these mechanisms is key to improving cardiovascular health in diabetes.
Conclusions:
- Hyperglycemia-induced pathways significantly impair vascular function in diabetes.
- Targeting these pathways presents a promising strategy for novel therapeutic approaches.
- Further research into these mechanisms can lead to improved cardiovascular outcomes for individuals with diabetes.
Related Concept Videos
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Glucose Homeostasis: Regulation of Blood Glucose
3.7K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.7K


